RAP 0.00% 20.5¢ resapp health limited

Cochlear $11.6 B market cap

  1. 6,718 Posts.
    lightbulb Created with Sketch. 850
    So I decided to do a back of napkin comparison with Cochlear.
    Their net is around $240 million p.a. and they have about 57 million shares...from what I could see. Their MC is about
    $11.6 Billion or so.
    If ResApp gets to an SP of $16.50 per share and they have 700 million shares their MC is around $11.6 billion same as is Cochlear's.
    If ResApp nets $1 billion p.a. then their SP should be around $17 ($1.40 net per share x 12).
    700,000,000 shares at $17 is $11.9 billion MC...
    250 million ResApp tests p.a. at $7 per test is $1.75 billion.
    Deduct 750 million for operating costs and kickbacks and whatever.
    ResApp net profit $1 billion ( 4 times Cochlear's net) divided by 700 million shares is $1.42 x 12 is $17 per share.
    One telehealth provider in China will do 350,000,000 bronchial tests next year.
    How long before ResApp do 250,000,000 tests in a year?
    I say two years...(check my sums glad for comments and corrections)
    All MHOO so do your own sums folks...then smile.
    Bought more again today...
    Whichever way you do the sums it as going to be large USA tests to be cool of course plus Sleep Apnea....don't forget this.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.